United States · Biotechnology startup

Coherus Biosciences

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Email

Funding reportedLast round: Post ipo equity

BiotechnologyRedwood City, United States

What company datasets say Coherus Biosciences raised

Funding, as reported

Reported in all$1.3Bin dollars
Rounds16
Last roundPost ipo equity
Last round dateMay 2023
Investors listed20

Founders and team

From Coherus Biosciences's own website and the SEC filings it signed: 10 on the team.

  • Dennis M. LanfearPresident & Chief Executive Officer
  • Andy RittenbergChief Legal Officer
  • Arvind SoodChief Strategy and Corporate Affairs Officer
  • Bryan McMichaelChief Financial Officer
  • Rebecca SunshineChief Human Resources Officer
  • Sameer GoregaokerChief Commercial Officer
  • Alan C. HermanExecutive Officeri
  • Barbara K. FinckExecutive Officeri
  • Jean Frederic J. ViretExecutive Officeri
  • Peter K. WatlerExecutive Officeri

On the board, as filediAugust J. TroendleChristos Bryan RichardsJames I. HealyMary T. SzelaV. Bryan Lawlis

On a portfolio page

Investors who name them

Each firm lists Coherus Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Coherus Biosciences in front of investors. Or tell us what we have wrong.

List your startupSend a correction